TC
IMA

T3 Companies’s ImageneBio Inc IMA Stock Holding History

T3 Companies’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,200
Closed -$91.1K – 190
2025
Q4 		$91.1K Buy
+13,200
New +$97.9K 0.11% 114

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

T3 Companies's IMA Position: Q1 2026 in Review

T3 Companies sold out of ImageneBio Inc (IMA) in Q1 2026, closing a stake of 13,200 shares — an estimated $91.1K sold.

T3 Companies first reported a position in IMA in Q4 2025 and held it in 1 quarter. The position peaked at $91.1K in Q4 2025. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

  • T3 Companies reported no remaining ImageneBio Inc position as of Q1 2026 after selling out during the quarter.
  • T3 Companies sold 13,200 ImageneBio Inc shares in Q1 2026, an estimated $91.1K.
  • T3 Companies first reported a position in ImageneBio Inc in Q4 2025 and held it in 1 quarter.
  • T3 Companies's ImageneBio Inc position peaked at $91.1K in Q4 2025.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on T3 Companies's 13F filing for Q1 2026, filed 7 May 2026.